Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age

Halstead, SB

Halstead, SB (reprint author), Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, 5824 Edson Lane N, Bethesda, MD 20852 USA.

VACCINE, 2017; 35 (47): 6355

Abstract

During a large scale clinical efficacy trial of the Sanofipasteur live-attenuated tetravalent dengue vaccine (Dengvaxia), features of hospitalized dis......

Full Text Link